Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Higher 25(OH)D levels were associated with lower mortality risk.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This is a retrospective cohort study analyzing data from nine consecutive cycles of the NHANES (2001−2018).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Age-specific benefits of Vitamin D and its association with mortality
Cohort study · PLOS One · 2025
Original publication title
Age-specific benefits of Vitamin D and its association with mortality
© 2025 Wang et al
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Vitamin D is a fat-soluble secosteroid that plays essential roles in calcium homeostasis, bone metabolism, and numerous other physiological processes. Vitamin D deficiency has been associated with increased risk of various diseases and mortality. However, population-based studies examining the relationship between vitamin D and mortality across different age groups remain limited.
Source: BackgroundAbstract: What methods does the paper describe?
To investigate the correlation between 25-hydroxyvitamin D [25(OH)D] levels, vitamin D status, and mortality in a cohort of 47,478 individuals aged 18 to 85 years.
Source: MethodsAbstract: Results
Higher 25(OH)D levels were associated with lower mortality risk. Compared to the vitamin D deficiency group, the Hazard ratios (HR) for all-cause mortality were 0.71 (95%CI: 0.66 to 0.76) in the insufficiency group and 0.64 (95%CI: 0.58 to 0.70) in the sufficiency group. The association varied by age: strongest in adults aged 40 to 59 years (HR: 0.74, 95% CI: 0.65 to 0.85), significant in those ≥60 years (HR: 0.86, 95% CI: 0.82 to 0.90), but non-significant in those aged 18 to 39 years. The RCS analysis revealed a non-linear relationship between 25(OH)D and mortality, with significant risk reduction observed between 59.25 to 261.45 nmol/L for the overall population.
The optimal 25(OH)D levels (lowest HR) varied by subgroups: 96.81 nmol/L for the overall population, 102.9 nmol/L for females, 67 nmol/L for ages 40 to 59, and 104.23 nmol/L for ages ≥60 years, while no significant association was found in ages 18 to 39 years.
Source: ResultsAbstract: Conclusion
Our findings suggest that Vitamin D are associated with mortality among the whole population. Individuals aged 40 to 59 may derive potential benefits from vitamin D supplementation.
Source: ConclusionAuthors’ abstract
Background
Vitamin D is a fat-soluble secosteroid that plays essential roles in calcium homeostasis, bone metabolism, and numerous other physiological processes. Vitamin D deficiency has been associated with increased risk of various diseases and mortality. However, population-based studies examining the relationship between vitamin D and mortality across different age groups remain limited.
Methods
To investigate the correlation between 25-hydroxyvitamin D [25(OH)D] levels, vitamin D status, and mortality in a cohort of 47,478 individuals aged 18 to 85 years.
Results
Higher 25(OH)D levels were associated with lower mortality risk. Compared to the vitamin D deficiency group, the Hazard ratios (HR) for all-cause mortality were 0.71 (95%CI: 0.66 to 0.76) in the insufficiency group and 0.64 (95%CI: 0.58 to 0.70) in the sufficiency group. The association varied by age: strongest in adults aged 40 to 59 years (HR: 0.74, 95% CI: 0.65 to 0.85), significant in those ≥60 years (HR: 0.86, 95% CI: 0.82 to 0.90), but non-significant in those aged 18 to 39 years. The RCS analysis revealed a non-linear relationship between 25(OH)D and mortality, with significant risk reduction observed between 59.25 to 261.45 nmol/L for the overall population.
The optimal 25(OH)D levels (lowest HR) varied by subgroups: 96.81 nmol/L for the overall population, 102.9 nmol/L for females, 67 nmol/L for ages 40 to 59, and 104.23 nmol/L for ages ≥60 years, while no significant association was found in ages 18 to 39 years.
Conclusion
Our findings suggest that Vitamin D are associated with mortality among the whole population. Individuals aged 40 to 59 may derive potential benefits from vitamin D supplementation.
Publication and source details
Original title: Age-specific benefits of Vitamin D and its association with mortality
Yan Wang; Xueqin Zhang; Xu Wang; Ju Li; Kai Wang
PLOS One · 2025
* E-mail: morrosun@hotmail.com, morrosun@njmu.edu.cn (KW); liju198461@njmu.edu.cn (JL)Competing Interests: The authors have declared that no competing interests exist.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:14:09.411754+00:00
DOI: 10.1371/journal.pone.0330959 · PMC12396682